Skip to content

Information about how we use cookies

This website uses cookies to provide you with the best possible experience of the website. By continuing to use the website, you agree to our use of cookies. More information about our privacy policy and how we handle cookies can be found here

Help links

  • Sitemap
  • Choose country
    • Swedish
    • Norwegian
    • Danish
    • Finnish
    • Dutch
Navamedic Navamedic

Main navigation

  • Portfolio
  • Investor relations
  • Newsroom
  • About Navamedic
  • Contact
Search

Newsroom

  • 2019
  • 2018
  • 2017
    • December
    • November
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2016

May

  • 2017-05-31

    Navamedic ASA: Granted European patent for Sippi® base technology

  • 2017-05-15

    Navamedic ASA: Notice of Annual General Meeting

  • 2017-05-10

    Navamedic ASA: Q1 2017 results

    Oslo, 10 May 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 78.2 million in the first quarter of 2017 (NOK 60.8 million in Q1 2016), representing a growth of 28.6%, in part due to a widened distribution across new European markets under the partnership with TopRidge Pharma.

  • 2017-05-04

    Navamedic ASA: Invitation to presentation of first quarter results 2017

    Navamedic ASA invites you to a presentation of the first quarter 2017 figures.

  • 2017-05-02

    Navamedic ASA: Enters into partnership agreement with Orexigen Therapeutics for Nordic launch of Mysimba®

    Oslo, May 2, 2017 – Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a five-year agreement with Orexigen Therapeutics Ireland, Ltd., the subsidiary of the American biopharmaceutical company Orexigen Therapeutics, Inc. (Nasdaq: OREX), for Nordic marketing and distribution of Mysimba®, a prescription pharmaceutical.

Show more
Top

Navamedic ASA

Fornebuveien 42-44 P.O. Box 107 N-1325 Lysaker Norway

Privacy Policy

Investor relations

  • The Share
  • Annual Reports
  • Quarterly Reports
  • IFRS
  • Presentations
  • Corporate Governance
  • Financial Calendar
  • IR Contacts
  • Product Launches

About Navamedic

  • Management
  • Board of Directors
  • Company History
  • Careers
  • Our Partners
  • Business Development
  • Privacy Policy

Copyright © 2016 Navamedic ASA Sitemap Contact

  • Facebook